Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized, Multicenter, Two Arms Double-blind Trial Versus Placebo, Evaluating the Interest of a Dietary Supplementation With Docosahexaenoic Acid (DHA) During Chemotherapy for Metastatic Breast Cancer

NCT01548534 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT01548534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01548534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized, Multicenter, Two Arms Double-blind Trial Versus Placebo, Evaluating the Interest of a Dietary Supplementation With Docosahexaenoic Acid (DHA) During Chemotherapy for Metastatic Breast Cancer
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Terminated
Start date
February 29, 2012
Completion date
June 30, 2014
Enrollment
65 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

estrogen receptor positive tumor, her-2 negative tumor, metastatic breast cancer, progesterone receptor positive tumor